Search Results 741-750 of 17139 for monoclonal antibody

1. Patients with blood cancer precursor at risk of developing cancer even after 30 years - Mayo Clinic News Network

   These are the findings of a study by Mayo Clinic researchers published in the Wednesday, Jan. 17, issue of the New England Journal of Medicine. Monoclonal ...

2. Sarcoma Study of MORAb-004 Utilization: Research and Clinical Evaluation

   Have a history of allergic reaction to prior monoclonal antibody or biologic agent Have received previous treatment with MORAb-004 (anti-TEM-1); Have a ...

3. Coronavirus Disease 2019 (COVID-19) Clinical Trials - Mayo Clinic Research

   ... antibody detectable targets on cancer cells (cancer vaccines or antibody ... Monoclonal Antibodies to Treat Hospitalized Patients with COVID-19 Rochester, MN.

4. A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid Tumors - Mayo Clinic

   A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid Tumors. Print details. Share; Facebook · Twitter.

5. Testing the Addition of an Anti-cancer Drug, ASTX727, to Chemotherapy (Paclitaxel) and Immunotherapy (Pembrolizumab) for Metastatic Triple-Negative Breast Cancer - Mayo Clinic

   Patients who have received prior PD-1/PD-L1 monoclonal antibodies in any disease setting are eligible. ... antibody agent, ASTX727 is a hypomethylating ...

6. Study Assessing Activity of Intravenous (IV) ABBV-383 Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   ... monoclonal antibody (mAb). - Must be naïve to treatment with B-cell maturation antigen (BCMA)-targeted therapy. - Must be eligible to receive the ...

7. A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Anti-N-Methyl-D-Aspartic Acid Receptor (NMDAR) Or Anti-Leucine-Rich Glioma-Inactivated 1 (LGI1) Encephalitis (Cielo) - Mayo Clinic

   * Any previous treatment with anti-CD19 antibody, complement inhibitors, neonatal Fc receptor antagonists, anti-B-lymphocyte stimulator monoclonal antibody * ...

8. Treatment of IgG4-Related Disease With Revlimid and Rituximab - Mayo Clinic

   Allergies: History of severe allergic reactions to human or chimeric monoclonal antibodies, murine protein, or lenalidomide; Substance abuse: Drug or alcohol ...

9. A Study of Using Lorvotuzumab Mertansine in Treating Younger Patients with Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial Sarcoma - Mayo Clinic

   Antibody-drug conjugates, such as lorvotuzumab mertansine, are created by ... monoclonal antibody; ≥ 2 weeks must have elapsed since local palliative ...

10. Innovative procedure marks clinical transplant milestone

    ... antibody levels. The researchers found that transplanting the liver first decreases a patient's donor-specific alloantibody (DSA) levels, helping to avoid ...